Senti Biosciences, Inc. (NASDAQ:SNTI) CEO Timothy K. Lu Sells 3,922 Shares

Senti Biosciences, Inc. (NASDAQ:SNTI) CEO Timothy K. Lu sold 3,922 shares of the firm’s stock in a transaction dated Tuesday, February 4th. The shares were sold at an average price of $4.07, for a total transaction of $15,962.54. Following the completion of the sale, the chief executive officer now owns 82,627 shares of the company’s stock, valued at $336,291.89. This trade represents a 4.53 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Senti Biosciences Trading Down 2.9 %

Shares of NASDAQ SNTI opened at $4.33 on Friday. Senti Biosciences, Inc. has a 52 week low of $1.52 and a 52 week high of $16.94. The firm has a 50-day moving average price of $4.57 and a 200 day moving average price of $3.13.

Analyst Ratings Changes

Separately, Chardan Capital reiterated a “buy” rating and issued a $10.00 price objective on shares of Senti Biosciences in a research note on Monday, December 2nd.

Senti Biosciences Company Profile

Senti Biosciences, Inc operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications.